• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铋基药物的当前及潜在应用

Current and potential applications of bismuth-based drugs.

作者信息

Keogan Donal M, Griffith Darren M

机构信息

Centre for Synthesis & Chemical Biology, Department of Pharmaceutical & Medicinal Chemistry, Royal College of Surgeons in Ireland, 123 St. Stephens Green, Dublin 2, Ireland.

出版信息

Molecules. 2014 Sep 23;19(9):15258-97. doi: 10.3390/molecules190915258.

DOI:10.3390/molecules190915258
PMID:25251194
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6271281/
Abstract

: Bismuth compounds have been used extensively as medicines and in particular for the treatment of gastrointestinal ailments. In addition to bismuth's well known gastroprotective effects and efficacy in treating H. pylori infection it also has broad anti-microbial, anti-leishmanial and anti-cancer properties. Aspects of the biological chemistry of bismuth are discussed and biomolecular targets associated with bismuth treatment are highlighted. This review strives to provide the reader with an up to date account of bismuth-based drugs currently used to treat patients and discuss potential medicinal applications of bismuth drugs with reference to recent developments in the literature. Ultimately this review aims to encourage original contributions to this exciting and important field.

摘要

铋化合物已被广泛用作药物,尤其用于治疗胃肠道疾病。除了铋众所周知的胃保护作用以及治疗幽门螺杆菌感染的功效外,它还具有广泛的抗菌、抗利什曼原虫和抗癌特性。本文讨论了铋的生物化学方面,并突出了与铋治疗相关的生物分子靶点。这篇综述力求为读者提供目前用于治疗患者的铋基药物的最新情况,并参照文献中的最新进展讨论铋药物的潜在医学应用。最终,这篇综述旨在鼓励对这一令人兴奋且重要的领域做出原创贡献。

相似文献

1
Current and potential applications of bismuth-based drugs.铋基药物的当前及潜在应用
Molecules. 2014 Sep 23;19(9):15258-97. doi: 10.3390/molecules190915258.
2
Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles.基于铋的化合物和纳米粒子的药物化学和生物医学应用。
Chem Soc Rev. 2021 Nov 1;50(21):12037-12069. doi: 10.1039/d0cs00031k.
3
Recent Research Trends on Bismuth Compounds in Cancer Chemoand Radiotherapy.近年来关于铋化合物在癌症化疗和放疗中的研究趋势。
Curr Med Chem. 2019;26(4):729-759. doi: 10.2174/0929867324666171003113540.
4
The use of bismuth in gastroenterology. The ACG Committee on FDA-Related Matters. American College of Gastroenterology.铋在胃肠病学中的应用。美国胃肠病学会FDA相关事务委员会。美国胃肠病学会。
Am J Gastroenterol. 1991 Jan;86(1):16-25.
5
Bismuth compounds in medicinal chemistry.铋化合物在药物化学中的应用。
Future Med Chem. 2012 Jul;4(11):1495-523. doi: 10.4155/fmc.12.95.
6
Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori Infection.系统方法揭示铋剂作用机制:除幽门螺杆菌感染之外的新医药应用。
Acc Chem Res. 2019 Jan 15;52(1):216-227. doi: 10.1021/acs.accounts.8b00439. Epub 2018 Dec 31.
7
Antimony and bismuth compounds in oncology.肿瘤学中的锑和铋化合物。
Crit Rev Oncol Hematol. 2002 Jun;42(3):217-24. doi: 10.1016/s1040-8428(01)00217-7.
8
Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome.铋化合物的生物学活性:新发现综述及尚未克服的旧挑战。
Molecules. 2023 Aug 7;28(15):5921. doi: 10.3390/molecules28155921.
9
Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.三价铋β-硫代酮配合物作为抗幽门螺杆菌抗生素和抗利什曼原虫药物。
Dalton Trans. 2014 Jan 21;43(3):1279-91. doi: 10.1039/c3dt52544a. Epub 2013 Nov 5.
10
Chemistry and Some Biological Potential of Bismuth and Antimony Dithiocarbamate Complexes.二硫代氨基甲酸盐配合物的化学性质及其某些生物学潜能。
Molecules. 2020 Jan 12;25(2):305. doi: 10.3390/molecules25020305.

引用本文的文献

1
Addressing the global challenge of bacterial drug resistance: insights, strategies, and future directions.应对细菌耐药性的全球挑战:见解、策略与未来方向。
Front Microbiol. 2025 Feb 24;16:1517772. doi: 10.3389/fmicb.2025.1517772. eCollection 2025.
2
Hinokitiol potentiates antimicrobial activity of bismuth drugs: a combination therapy for overcoming antimicrobial resistance.扁柏酚增强铋剂的抗菌活性:一种克服抗菌耐药性的联合疗法。
RSC Med Chem. 2025 Jan 31. doi: 10.1039/d4md00860j.
3
Should Metronidazole Be Included in Second-Line Treatment After Standard Triple Therapy for Helicobacter pylori?: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

本文引用的文献

1
Preparation, characterization, and anti-Helicobacter pylori activity of Bi3+-Hericium erinaceus polysaccharide complex.Bi3+-香菇多糖复合物的制备、表征及抗幽门螺杆菌活性研究。
Carbohydr Polym. 2014 Sep 22;110:231-7. doi: 10.1016/j.carbpol.2014.03.081. Epub 2014 Apr 2.
2
Novel triphenylantimony(V) and triphenylbismuth(V) complexes with benzoic acid derivatives: structural characterization, in vitro antileishmanial and antibacterial activities and cytotoxicity against macrophages.新型三苯基锑(V)和三苯基铋(V)与苯甲酸衍生物的配合物:结构表征、体外抗利什曼原虫和抗菌活性以及对巨噬细胞的细胞毒性
Molecules. 2014 May 12;19(5):6009-30. doi: 10.3390/molecules19056009.
3
幽门螺杆菌标准三联疗法后二线治疗中是否应包含甲硝唑?:随机对照试验的系统评价和荟萃分析
Helicobacter. 2025 Jan-Feb;30(1):e70010. doi: 10.1111/hel.70010.
4
Periodic Table of Immunomodulatory Elements and Derived Two-Dimensional Biomaterials.免疫调节元素周期表及衍生的二维生物材料
Adv Sci (Weinh). 2025 Feb;12(6):e2406324. doi: 10.1002/advs.202406324. Epub 2025 Jan 3.
5
Group VA Aromatic Thiosemicarbazone Complexes: Synthesis, Characterization, Biological Activity, and Topological Studies.VA 族芳基硫代卡巴腙配合物的合成、表征、生物活性及拓扑研究。
Int J Mol Sci. 2024 Oct 8;25(19):10794. doi: 10.3390/ijms251910794.
6
A Second Wind for Inorganic APIs: Leishmanicidal and Antileukemic Activity of Hydrated Bismuth Oxide Nanoparticles.无机活性药物成分的新活力:水合氧化铋纳米颗粒的抗利什曼原虫和抗白血病活性
Pharmaceutics. 2024 Jun 29;16(7):874. doi: 10.3390/pharmaceutics16070874.
7
Efficient Europium Sensitization via Low-Level Doping in a 2-D Bismuth-Organic Coordination Polymer.二维铋有机配位聚合物中通过低水平掺杂实现高效铕敏化
Cryst Growth Des. 2023 Apr 5;23(5):3330-3337. doi: 10.1021/acs.cgd.2c01475. eCollection 2023 May 3.
8
Cytotoxicity of bismuth(III) dithiocarbamate derivatives by promoting a mitochondrial-dependent apoptotic pathway and suppressing MCF-7 breast adenocarcinoma cell invasion.二硫代氨基甲酸铋衍生物通过促进线粒体依赖性凋亡途径和抑制 MCF-7 乳腺癌腺癌细胞侵袭来发挥细胞毒性作用。
J Biol Inorg Chem. 2024 Mar;29(2):217-241. doi: 10.1007/s00775-023-02041-x. Epub 2024 Feb 18.
9
Biosynthesis of ZnO, BiO and ZnO-BiO bimetallic nanoparticles and their cytotoxic and antibacterial effects.氧化锌、氧化铋和氧化锌-氧化铋双金属纳米粒子的生物合成及其细胞毒性和抗菌作用。
ChemistryOpen. 2024 Apr;13(4):e202300176. doi: 10.1002/open.202300176. Epub 2024 Jan 17.
10
Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome.铋化合物的生物学活性:新发现综述及尚未克服的旧挑战。
Molecules. 2023 Aug 7;28(15):5921. doi: 10.3390/molecules28155921.
Main group bismuth(III), gallium(III) and diorganotin(IV) complexes derived from bis(2-acetylpyrazine)thiocarbonohydrazone: synthesis, crystal structures and biological evaluation.
主族铋(III)、镓(III)和二有机锡(IV)配合物来源于双(2-乙酰基吡嗪)硫代碳酰肼:合成、晶体结构和生物评价。
Dalton Trans. 2014 Apr 7;43(13):5182-9. doi: 10.1039/c4dt00077c.
4
Metallodrugs in medicinal inorganic chemistry.药物无机化学中的金属药物
Chem Rev. 2014 Apr 23;114(8):4540-63. doi: 10.1021/cr400460s. Epub 2014 Jan 23.
5
Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.三价铋β-硫代酮配合物作为抗幽门螺杆菌抗生素和抗利什曼原虫药物。
Dalton Trans. 2014 Jan 21;43(3):1279-91. doi: 10.1039/c3dt52544a. Epub 2013 Nov 5.
6
Treatment of Helicobacter pylori infection 2013.2013 年幽门螺杆菌感染治疗。
Helicobacter. 2013 Sep;18 Suppl 1:58-65. doi: 10.1111/hel.12075.
7
Extragastric diseases and Helicobacter pylori.胃外疾病与幽门螺杆菌。
Helicobacter. 2013 Sep;18 Suppl 1:44-51. doi: 10.1111/hel.12077.
8
213Bi radioimmunotherapy with an anti-mCD138 monoclonal antibody in a murine model of multiple myeloma.213Bi 放射性免疫疗法联合抗 mCD138 单克隆抗体治疗多发性骨髓瘤的小鼠模型。
J Nucl Med. 2013 Sep;54(9):1597-604. doi: 10.2967/jnumed.112.111997.
9
Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer.幽门螺杆菌引起的慢性胃炎和胃癌风险评估。
Gastroenterol Res Pract. 2013;2013:393015. doi: 10.1155/2013/393015. Epub 2013 Jul 29.
10
Nanotechnology as a therapeutic tool to combat microbial resistance.纳米技术作为一种治疗工具,用于对抗微生物耐药性。
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1803-15. doi: 10.1016/j.addr.2013.07.011. Epub 2013 Jul 24.